Heart rate variability during chronic hemodialysis and after renal transplantation : Studies in patients without and with systemic amyloidosis

• Published in: Journal of the American Society of Nephrology 1999-09, Vol.10 (9), p.1972-1981
• Main Authors: RUBINGER, D, SAPOZNIKOV, D, POLLAK, A, POPOVTZER, M. M, LURIA, M. H
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Amyloidosis - complications; Amyloidosis - physiopathology; Analysis of Variance; Autonomic Nervous System Diseases - complications; Autonomic Nervous System Diseases - physiopathology; Biological and medical sciences; Case-Control Studies; Female; Heart Rate; Humans; Kidney Transplantation - physiology; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; Nephropathies. Renovascular diseases. Renal failure; Renal Dialysis; Renal failure; Uremia - complications; Uremia - physiopathology; Uremia - therapy
• ISSN: 1046-6673; 1533-3450
• DOI: 10.1681/asn.v1091972

The present study was undertaken to compare heart rate variability (HRV) values in patients on maintenance hemodialysis with no evidence of ischemic or hypertensive heart diseases to those of age- and gender-matched healthy individuals and those of patients after renal transplantation. To assess the effects of a common confounding factor, HRV values were also determined in patients with systemic amyloidosis, in chronic hemodialysis, and after successful renal transplantation. Spectral analyses of RR intervals from continuous electrocardiogram recordings were performed to quantify ultra low frequency, very low frequency, low frequency, and high frequency powers. HRV determinations were all significantly reduced in uremic patients undergoing hemodialysis compared with the healthy control subjects, especially in those with systemic amyloidosis. Renal transplantation normalized HRV in most patients; HRV, however, remained reduced in isolated amyloidosis patients with cardiac or adrenal involvement. HRV circadian day/night differences were preserved in hemodialysis patients and after renal transplantation in those without amyloidosis but not in those with amyloidosis. These data suggest that reduced HRV in chronic hemodialysis patients may precede other manifestations of cardiovascular disease. In uremic patients with amyloidosis, a more severe form of autonomic failure may occur. Successful transplantation corrects HRV abnormalities in most patients, suggesting that the autonomic dysfunction of uremia is caused by humoral factors reversed by the normalization of the renal function.